Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%), etc.
Apr 12 18:53 ET
Eliem Therapeutics | DEFA14A: Others
Apr 11 08:14 ET
Eliem Therapeutics | 8-K: Current report
Apr 11 08:04 ET
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie
Apr 8 17:38 ET
Eliem Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 28 16:35 ET
Eliem Therapeutics | 10-K: Annual report
Mar 28 16:10 ET
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pimblett Emily
Mar 20 16:38 ET
Eliem Therapeutics | 8-K: Current report
Mar 19 13:33 ET
Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%), etc.
Mar 18 16:51 ET
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie
Mar 4 11:10 ET
Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Braden M Leonard(8.5%),BML Investment Partners, L.P.(7.9%)
Feb 7 11:56 ET
Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(47.7%),Peter Kolchinsky(47.7%), etc.
Nov 17, 2023 16:30 ET
Eliem Therapeutics: Q3 2023 Earnings Report
Nov 14, 2023 16:01 ET
Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Nov 13, 2023 17:13 ET
Eliem Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 10, 2023 16:06 ET
Eliem Therapeutics | 8-K: Current report
Jul 20, 2023 06:55 ET
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
May 22, 2023 17:22 ET
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Tate Simon
May 22, 2023 17:13 ET
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ratcliffe Liam
May 22, 2023 17:11 ET
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dunn Judith
May 22, 2023 17:08 ET
No Data
No Data